Sanuwave Health Debt to Equity Ratio 2012-2025 | SNWV
Current and historical debt to equity ratio values for Sanuwave Health (SNWV) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Sanuwave Health debt/equity for the three months ending September 30, 2025 was 0.00.
| Sanuwave Health Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.04B | $0.00B | -13.15 |
| 2025-06-30 | $0.05B | $-0.02B | -3.24 |
| 2025-03-31 | $0.05B | $-0.02B | -2.78 |
| 2024-12-31 | $0.04B | $-0.01B | -3.37 |
| 2024-09-30 | $0.08B | $-0.06B | -1.36 |
| 2024-06-30 | $0.06B | $-0.04B | -1.53 |
| 2024-03-31 | $0.07B | $-0.05B | -1.49 |
| 2023-12-31 | $0.07B | $-0.04B | -1.52 |
| 2023-09-30 | $0.09B | $-0.07B | -1.31 |
| 2023-06-30 | $0.08B | $-0.06B | -1.32 |
| 2023-03-31 | $0.07B | $-0.05B | -1.33 |
| 2022-12-31 | $0.06B | $-0.04B | -1.49 |
| 2022-09-30 | $0.05B | $-0.03B | -1.61 |
| 2022-06-30 | $0.05B | $-0.03B | -1.55 |
| 2022-03-31 | $0.05B | $-0.04B | -1.46 |
| 2021-12-31 | $0.06B | $-0.04B | -1.48 |
| 2021-09-30 | $0.05B | $-0.03B | -1.65 |
| 2021-06-30 | $0.05B | $-0.03B | -1.78 |
| 2021-03-31 | $0.04B | $-0.02B | -2.22 |
| 2020-12-31 | $0.04B | $-0.01B | -2.68 |
| 2020-09-30 | $0.04B | $-0.01B | -4.61 |
| 2020-06-30 | $0.02B | $-0.02B | -1.23 |
| 2020-03-31 | $0.02B | $-0.01B | -1.25 |
| 2019-12-31 | $0.01B | $-0.01B | -1.34 |
| 2019-09-30 | $0.02B | $-0.01B | -1.12 |
| 2019-06-30 | $0.02B | $-0.02B | -1.09 |
| 2019-03-31 | $0.02B | $-0.02B | -1.09 |
| 2018-12-31 | $0.02B | $-0.02B | -1.08 |
| 2018-09-30 | $0.01B | $-0.01B | -1.05 |
| 2018-06-30 | $0.02B | $-0.02B | -1.09 |
| 2018-03-31 | $0.02B | $-0.01B | -1.07 |
| 2017-12-31 | $0.01B | $-0.01B | -1.13 |
| 2017-09-30 | $0.01B | $-0.01B | -1.06 |
| 2017-06-30 | $0.01B | $-0.01B | -1.08 |
| 2017-03-31 | $0.01B | $-0.01B | -1.13 |
| 2016-12-31 | $0.01B | $-0.01B | -1.15 |
| 2016-09-30 | $0.01B | $-0.01B | -1.20 |
| 2016-06-30 | $0.01B | $-0.01B | -1.12 |
| 2016-03-31 | $0.01B | $-0.01B | -1.24 |
| 2015-12-31 | $0.01B | $-0.01B | -1.16 |
| 2015-09-30 | $0.01B | $-0.01B | -1.29 |
| 2015-06-30 | $0.01B | $0.00B | -1.61 |
| 2015-03-31 | $0.01B | $0.00B | -2.30 |
| 2014-12-31 | $0.01B | $0.00B | -4.01 |
| 2014-09-30 | $0.01B | $0.00B | -15.03 |
| 2014-06-30 | $0.01B | $0.00B | 6.04 |
| 2014-03-31 | $0.01B | $0.00B | 4.00 |
| 2013-12-31 | $0.01B | $-0.01B | -1.26 |
| 2013-09-30 | $0.01B | $-0.01B | -1.29 |
| 2013-06-30 | $0.01B | $-0.01B | -1.14 |
| 2013-03-31 | $0.01B | $-0.01B | -1.21 |
| 2012-12-31 | $0.01B | $-0.01B | -1.28 |
| 2012-09-30 | $0.01B | $-0.01B | -1.41 |
| 2012-06-30 | $0.01B | $0.00B | -1.79 |
| 2012-03-31 | $0.01B | $0.00B | -2.48 |
| 2011-12-31 | $0.01B | $0.00B | -5.01 |
| 2011-09-30 | $0.01B | $0.00B | 23.47 |
| 2011-06-30 | $0.01B | $0.00B | 3.82 |
| 2011-03-31 | $0.01B | $-0.01B | -1.58 |
| 2010-12-31 | $0.01B | $-0.01B | -1.29 |
| 2010-09-30 | $0.02B | $-0.01B | -1.28 |
| 2010-06-30 | $0.02B | $-0.01B | -1.36 |
| 2010-03-31 | $0.01B | $-0.01B | -1.59 |
| 2009-12-31 | $0.01B | $-0.01B | -2.00 |
| 2009-09-30 | $0.01B | $0.00B | -3.08 |
| 2009-06-30 | $0.00B | $0.00B | -1.01 |
| 2009-03-31 | $0.00B | $0.00B | -1.06 |
| 2008-12-31 | $0.01B | $0.00B | -3.50 |
| 2008-09-30 | $0.00B | $0.00B | -1.05 |
| 2008-06-30 | $0.00B | $0.00B | -1.11 |
| 2008-03-31 | $0.00B | $0.00B | -1.05 |
| 2007-12-31 | $0.00B | $0.00B | -1.11 |
| 2007-09-30 | $0.00B | 0.00 | |
| 2007-06-30 | $0.00B | 0.00 | |
| 2007-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.213B | $0.033B |
| SANUWAVE Health, Inc. is engaged in the development and commercialization of non-invasive, biological response-activating devices for the repair and regeneration of tissue, musculoskeletal and vascular structures. The Company's product candidates include its proprietary PACE technology applicable in wound healing, orthopedic/spine, plastic/cosmetic and cardiac conditions; and dermaPACE for treatment of the skin and subcutaneous soft tissue. The Company's products help in activating biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, helping to restore the body's normal healing processes and regeneration. SANUWAVE Health, Inc. is based in Alpharetta, USA. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $195.936B | 21.88 |
| EssilorLuxottica (ESLOY) | France | $142.091B | 0.00 |
| Stryker (SYK) | United States | $140.083B | 26.86 |
| Medtronic (MDT) | Ireland | $127.548B | 17.67 |
| Boston Scientific (BSX) | United States | $110.783B | 24.50 |
| Medline (MDLN) | United States | $58.526B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.093B | 0.00 |
| ResMed (RMD) | United States | $36.791B | 24.57 |
| GE HealthCare Technologies (GEHC) | United States | $36.615B | 17.54 |
| Agilent Technologies (A) | United States | $35.584B | 22.55 |
| Koninklijke Philips (PHG) | Netherlands | $30.091B | 17.86 |
| Terumo (TRUMY) | Japan | $21.610B | 25.26 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.115B | 11.76 |
| Insulet (PODD) | United States | $17.076B | 53.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $15.372B | 0.00 |
| Baxter (BAX) | United States | $10.182B | 8.72 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.921B | 25.86 |
| Demant (WILYY) | Denmark | $6.042B | 0.00 |
| Envista Holdings (NVST) | United States | $4.747B | 24.14 |
| Lantheus Holdings (LNTH) | United States | $4.601B | 14.02 |
| BillionToOne (BLLN) | United States | $4.056B | 0.00 |
| ICU Medical (ICUI) | United States | $3.577B | 22.71 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.263B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.160B | 14.91 |
| Haemonetics (HAE) | United States | $2.684B | 11.74 |
| Neogen (NEOG) | United States | $2.380B | 52.10 |
| Phibro Animal Health (PAHC) | United States | $2.118B | 18.66 |
| Perrigo (PRGO) | Ireland | $2.001B | 5.01 |
| LeMaitre Vascular (LMAT) | United States | $1.989B | 40.03 |
| Curaleaf Holdings (CURLF) | Canada | $1.642B | 0.00 |
| AtriCure (ATRC) | United States | $1.623B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.602B | 11.12 |
| Kestra Medical Technologies (KMTS) | United States | $1.571B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.446B | 63.36 |
| AdaptHealth (AHCO) | United States | $1.381B | 20.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.358B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.070B | 317.57 |
| Capricor Therapeutics (CAPR) | United States | $1.026B | 0.00 |
| InMode (INMD) | Israel | $0.906B | 9.93 |
| Tilray Brands (TLRY) | Canada | $0.875B | 0.00 |
| Valneva SE (VALN) | France | $0.868B | 0.00 |
| Omeros (OMER) | United States | $0.829B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.757B | 0.00 |
| CeriBell (CBLL) | United States | $0.733B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.566B | 13.52 |
| Brainsway (BWAY) | Israel | $0.451B | 76.63 |
| Canopy Growth (CGC) | Canada | $0.436B | 0.00 |
| Cerus (CERS) | United States | $0.430B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.396B | 0.00 |
| SNDL (SNDL) | Canada | $0.386B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.328B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.315B | 25.09 |
| Evolus (EOLS) | United States | $0.279B | 0.00 |
| Quanterix (QTRX) | United States | $0.268B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.243B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.205B | 18.42 |
| High Tide (HITI) | Canada | $0.203B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.201B | 59.17 |
| OraSure Technologies (OSUR) | United States | $0.197B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.182B | 0.00 |
| Organigram Global (OGI) | Canada | $0.174B | 0.00 |
| Accendra Health (ACH) | United States | $0.173B | 1.74 |
| Vireo Growth (VREOF) | United States | $0.170B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.168B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.42 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.100B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.26 |
| Exagen (XGN) | United States | $0.074B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 25.39 |
| Sharps Technology (STSS) | United States | $0.051B | 0.00 |
| Nephros (NEPH) | United States | $0.044B | 31.54 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.035B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 15.35 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| INLIF (INLF) | China | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |